David Sidransky
David Sidransky
Dirección de correo verificada de jhmi.edu
Citado por
Citado por
p53 mutations in human cancers
M Hollstein, D Sidransky, B Vogelstein, CC Harris
Science 253 (5015), 49-53, 1991
Participation of p53 protein in the cellular response to DNA damage
MB Kastan, O Onyekwere, D Sidransky, B Vogelstein, RW Craig
Cancer research 51 (23 Part 1), 6304-6311, 1991
A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination …
CR Boland, SN Thibodeau, SR Hamilton, D Sidransky, JR Eshleman, ...
Cancer research 58 (22), 5248-5257, 1998
World Health Organization classification of tumours: pathology and genetics of head and neck tumours
L Barnes, J Eveson, P Reichart, D Sidransky
IARC publications, 2005
Evidence for a causal association between human papillomavirus and a subset of head and neck cancers
ML Gillison, WM Koch, RB Capone, M Spafford, WH Westra, L Wu, ...
Journal of the National Cancer Institute 92 (9), 709-720, 2000
5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers
A Merlo, JG Herman, L Mao, DJ Lee, E Gabrielson, PC Burger, SB Baylin, ...
Nature medicine 1 (7), 686-692, 1995
Pathology and genetics of head and neck tumours
L Barnes, JW Eveson, D Sidransky, P Reichart
IARC, 2005
Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers
JG Herman, A Merlo, LI Mao, RG Lapidus, JPJ Issa, NE Davidson, ...
Cancer research 55 (20), 4525-4530, 1995
Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1
N Agrawal, MJ Frederick, CR Pickering, C Bettegowda, K Chang, RJ Li, ...
Science 333 (6046), 1154-1157, 2011
Genetic progression model for head and neck cancer: implications for field cancerization
J Califano, P Van Der Riet, W Westra, H Nawroz, G Clayman, ...
Cancer research 56 (11), 2488-2492, 1996
Head and neck cancer
A Forastiere, W Koch, A Trotti, D Sidransky
New England Journal of Medicine 345 (26), 1890-1900, 2001
Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients
M Esteller, M Sanchez-Cespedes, R Rosell, D Sidransky, SB Baylin, ...
Cancer research 59 (1), 67-70, 1999
BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer
M Xing, WH Westra, RP Tufano, Y Cohen, E Rosenbaum, KJ Rhoden, ...
The Journal of Clinical Endocrinology & Metabolism 90 (12), 6373-6379, 2005
Identification of p53 gene mutations in bladder cancers and urine samples
D Sidransky, A Von Eschenbach, YC Tsai, P Jones, I Summerhayes, ...
Science 252 (5006), 706-709, 1991
BRAF mutation in papillary thyroid carcinoma
Y Cohen, M Xing, E Mambo, Z Guo, G Wu, B Trink, U Beller, WH Westra, ...
Journal of the National Cancer Institute 95 (8), 625-627, 2003
Dysfunctional KEAP1–NRF2 interaction in non-small-cell lung cancer
A Singh, V Misra, RK Thimmulappa, H Lee, S Ames, MO Hoque, ...
PLoS Med 3 (10), e420, 2006
Facile detection of mitochondrial DNA mutations in tumors and bodily fluids
MS Fliss, H Usadel, OL Caballero, L Wu, MR Buta, SM Eleff, J Jen, ...
Science 287 (5460), 2017-2019, 2000
Frequent inactivation of PTEN/MMAC1 in primary prostate cancer
P Cairns, K Okami, S Halachmi, N Halachmi, M Esteller, JG Herman, ...
Cancer research 57 (22), 4997-5000, 1997
Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors
D Sidransky, T Tokino, KW Kinzler, B Levin, P Frost, B Vogelstein
Science 256 (5053), 102-105, 1992
DPC4 gene in various tumor types
M Schutte, RH Hruban, L Hedrick, KR Cho, GM Nadasdy, CL Weinstein, ...
Cancer research 56 (11), 2527-2530, 1996
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20